Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis

被引：28
|
作者：
Müller, FMC
Kurzai, O
Hacker, J
Frosch, M
Mühlschlegel, F
机构：
[1] Univ Wurzburg, Dept Paediat, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Inst Mol Biol Infect, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 05期
关键词：
D O I：
10.1093/jac/48.5.713
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Micafungin (FK-463), a member of the new candin family of antifungal agents, was highly active against clinical isolates of Candida albicans and Candida dubliniensis. The in vitro activity of micafungin suggested that it was more potent than fluconazole, flucytosine, amphotericin B or voriconazole against C. albicans, and comparable or moderately less effective against C. dubliniensis isolates when high-resolution medium (HR) was used. Lower MICs of micafungin were recorded when RPMI 2% or AM3 2% media were used, indicating an influence of the growth medium on the MIC.
引用
收藏
页码：713 / 715
页数：3
相关论文
共 50 条
  • [1] In vitro activity of micafungin (FK-463) against Candida spp.:: Microdilution, time-kill, and postantifungal-effect studies
    Ernst, EJ
    Roling, EE
    Petzold, CR
    Keele, DJ
    Klepser, ME
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) : 3846 - 3853
  • [2] Micafungin activity against Candida bloodstream isolates:: effect of growth medium and susceptibility testing method
    Pai, Manjunath P.
    Jones, Ariel L.
    Mullen, Casey K.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (01) : 129 - 132
  • [3] In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: Comparison of yeast-like and mycelial forms
    Nakai, T
    Uno, J
    Ikeda, F
    Tawara, S
    Nishimura, K
    Miyaji, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1376 - 1381
  • [4] A Comparison of the Antifungal Activity of Herbal Toothpastes against Other Brands of Toothpastes on Clinical Isolates of Candida albicans and Candida dubliniensis
    Ellepola, Arjuna N. B.
    Khan, Zia U.
    Chandy, Rachel
    Philip, Leeba
    MEDICAL PRINCIPLES AND PRACTICE, 2010, 20 (02) : 112 - 117
  • [5] In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans Isolates
    Jacobson, Melissa J.
    Steckelberg, Kathryn E.
    Piper, Kerryl E.
    Steckelberg, James M.
    Patel, Robin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) : 2638 - 2639
  • [6] Antifungal activity of sertaconazole in vitro against clinical isolates of Candida spp.
    MartinMazuelos, E
    Aller, AI
    Morilla, D
    Montero, O
    CHEMOTHERAPY, 1996, 42 (02) : 112 - 117
  • [7] In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
    Qiao, Jianjun
    Gao, Peiping
    Jiang, Xiaoling
    Fang, Hong
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2013, 12
  • [8] In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida
    Jianjun Qiao
    Peiping Gao
    Xiaoling Jiang
    Hong Fang
    Annals of Clinical Microbiology and Antimicrobials, 12
  • [9] In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents
    Pfaller, MA
    Messer, SA
    Gee, S
    Joly, S
    Pujol, C
    Sullivan, DJ
    Coleman, DC
    Soll, DR
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 870 - 872
  • [10] In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species
    Nishi, Isao
    Sunada, Atsuko
    Toyokawa, Masahiro
    Asari, Seishi
    Iwatani, Yoshinori
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (01) : 1 - 5
12345